Breast Cancer Survivor’s Views on Duration of Follow Up

Background: Breast cancer is one of the commonest cancers in women in the UK and western countries [1]. Follow ups after breast cancer diagnosis is usual practice, but there is no agreed consensus among breast care providers on frequency or duration of follow up after diagnosis and adjuvant treatment. The aim of this study is to find out women’s views on the period of the clinical follow up after breast cancer diagnosis. Method: This was a surveillance study in Greenock and Glasgow in the UK (Between September 2009 and December 2010). The study group comprised of 446 Women, 246 with the history of breast cancer diagnosed 1 - 10 years, (median 4.2 years) were asked to complete a questionnaire about their views of preferred duration of follow up while they were waiting for the annual review at a breast clinic, the same questionnaire was completed by 200 women with no history of breast cancer. Results: Between September 2009 and December 2010, 246 patients were included in the study. 40% of patients were within the first three years of follow up, 27% between the 4th and 6th year and 33% were in follow-up for more than 6 years. 63% of cancer survivors think that, 10 years of follow up is necessary for reassurance, detection and treatment of any new, recurrent or spread of their breast cancer. 14% and 22% of women with a history of breast cancer preferred 3 and 5 years review by trained Radiologist/GP respectively. Women without a history of breast cancer were different in their thoughts about follow up after breast cancer: 10%, 25%, and 30% chosen 10, 5 and 3 years, 35% preferred don’t know the answer. Conclusion: Follow up programs for breast cancer survivors need to be organized, evidence based, flexible and patient tailored. Patients’ views should be taken into account when considering provision of follow-up care for breast cancer patients.

Fifty-Year-Follow-up Results Compared with Shorter Follow-up of Breast Cancer Patients Undergoing Radical Mastectomy with or without Adjuvant Radiotherapy

Background: To evaluate the effect of follow-up length on the outcome of breast cancer patients, we compared the 50- and 25-year follow-up results in terms of cure rate, overall mortality and mortalities from breast cancer, second cancer, and benign diseases. Methods: 763 patients treated for breast cancer between February 1953 and September 1976, were followed up until December 2014. They were divided into two cohorts;earlier cohort exclusively underwent radical mastectomy plus adjuvant radiotherapy, while later cohort had radical mastectomy alone. Assuming that in all patients follow-up was terminated at 50 or 25 years after diagnosis, likelihood ratio test and stratified Log-rank tests were performed to evaluate the differences in cure rate and overall survival between the two cohorts. Results: During the 50 years, radical mastectomy alone compared with radical mastectomy plus adjuvant radiotherapy is associated with a significantly higher cure rate, and higher survivals regardless of whether the death was from breast cancer, second cancer, benign causes or any causes. However, if follow-up information is limited to 25 years, the advantage of radical mastectomy alone is partly offset and the survival difference between the two cohorts becomes less significant. Conclusion: Radiotherapy to breast cancer may adversely affect not only mortality from breast cancer, but mortalities unrelated to breast cancer. Since such deaths occur later, they may fail to be detected unless follow-up is long enough. Thus, deleterious effects of radiotherapy may be underestimated. Exceedingly long follow-up is required to accurately estimate the cure rate and the long-term effect of radiotherapy.

Accuracy of Ultrasound Examination of Loco-Regional Lymph Nodes in Breast Cancer Follow-Up and Its Role in the Axillary Surgical Management

Objective: Major international guidelines have not standardized the sequence of diagnostic examinations during the follow-up of a patient with a diagnosed breast cancer. The aim of this study is to investigate the accuracy of sonography in the diagnosis of loco-regional lymphatic recurrences in comparison to the core needle biopsy results. Materials and Methods: Among 6455 patients who were followed up with clinical examination, mammography and ultrasound between January 2004 and November 2011, 125 (1.93%) patients had to be investigated with a core needle biopsy of a sonographically suspicious loco-regional lymph node. Results: Among the whole series, a total of 142 ultrasound-guided core needle biopsies were performed. Follow-up for the primary tumor lasted for a median time of 6.1 years (range 1 - 27 years). Ultrasound of suspicious loco-regional lymph nodes showed a sensitivity of 89.5%, a specificity of 87.1% and a positive predictive value of 89.5%. Conclusions: In our experience, ultrasound of suspicious loco-regional lymph nodes showed good accuracy and it should be a part of the standard examinations performed during follow-up for breast cancer.

Information Needs of Breast Cancer Patients at Cancer Diseases Hospital, Lusaka, Zambia

Background: Breast cancer is the second most common cancer worldwide and the second most common among Zambian women. Breast cancer diagnosis being a stressful experience, causes psychological and emotional disruption that can be abated by meeting information needs of the affected patients. In light of the escalating cases of Breast cancer among the Zambian women, the study examined a special aspect of cancer management which is usually neglected in most cases. Aim: The main objective of the study was to assess information needs of breast cancer patients at the Cancer Diseases Hospital in Lusaka, Zambia using a modified structured interview schedule adopted from the Toronto Information Needs Questionnaire-Breast Cancer (TINQ-BC). Methods: A descriptive cross-sectional design was used to elicit the information needs of breast cancer patients. One hundred and ten (97% response rate) participants were selected using simple random sampling method and data was collected using a modified structured interview schedule adopted from the Toronto Information Needs Questionnaire-Breast Cancer (TINQ-BC). Stata 10.0 (StataCorp, 2008) was employed for all quantitative data analysis and graphical presentation of data. Results: The overall score for information needs was obtained by adding the scores across all the five information needs categories which were further divided into three categories namely: low important scores, of less than 50%, moderately important scores of 50% - 70% and highly important scores ranged above 70% of the 200 total scores. Out of the 110 participants recruited, 88 (80%) indicated that the information across the five categories was moderately important. Logistic regression of information needs and posited determinants revealed that anxiety levels;education level;presence of co-morbidity;and being on treatment were significant determinants of patients’ informational needs (Effect’s p ≤ 0.05). Conclusion: The findings of this study support the idea that breast cancer patients are seeking more information on their illness, hence information provision is one of the most important factors for providing high quality cancer care across the whole cancer continuum. Therefore, appreciating the information needs of breast cancer patients is substantial in improving care.

Needs and Opportunities for Information in Patients with Metastatic Breast Cancer Attending a Tertiary Hospital in Tanzania—A Qualitative Study

Background: The majority of breast cancer patients in Tanzania present with advanced disease, and a significant proportion has metastatic breast cancer (MBC) on presentation or develops it during the course of their follow-up. With few treatment options to choose from, such patients often benefit from empathic support and access to information to help them make treatment decisions based on their individual circumstances and needs. Patients with MBC have been shown to present with unique physical, social and psychological needs that require additional time, counselling and availability of health care providers in addition to the routine options available to other patients. In resource-limited settings, the needs of such patients are often unknown and unaddressed, which adds to the anxiety associated with the diagnosis and its treatment. Materials and methods: This descriptive qualitative study was conducted using 3 focus group discussions with a total of 17 participants with metastatic breast cancer (MBC) attending Ocean Road Cancer Institute in Dar es Salaam, Tanzania. Participants were purposively selected for the study from outpatient clinics and inpatient wards. A semi-structured FGD guide was used to moderate discussions and analysis was done using a thematic approach. Results: The median age of participants was 51 (range 33 - 81 years) with an average of 4 months (range 1 - 12 months) from diagnosis of BC to the interview. 4 (24%) were diagnosed with MBC on first presentation (denovo). Participants spoke about the importance of accurate BC-related information in allowing timely referral and treatment both in the community and within the health system. They recognized the role of mass and social media in increasing awareness about BC and identified myths surrounding cancer treatment especially mastectomy. Correct and timely information at points of care, through media platforms and via ambassadors/patient support groups was perceived as a means to avoiding delays and securing early and effective treatment. Conclusion: Patients with MBC in Tanzania have many unmet informational needs in relation to their disease. Accurate BC-related information is important in allowing early detection and diagnosis. At the community level, provision of information through established media platforms and the use of patient advocates may help to enable early referral and treatment of patients.

Main controversies in breast cancer

In this article, we have reviewed available evidence for diagnosis, treatment, and follow-up in female breast cancer(BC). Into daily clinical practice some controversies are occurred. Especially, in the diagnosis field, despite the fact that the optimal age in which screening mammography should start is a subject of intense controversy, there is a shift toward the beginning at the age of 40 although it is suggested that the net benefit is small for women aged 40 to 49 years. In addition, a promising tool in BC screening seems to be breast tomosynthesis. Other tools such as 3D ultrasound and shear wave elastography(SWE) are full of optimism in BC screening although ultrasonography is not yet a first-line screening method and there is insufficient evidence to recommend the systemic use of the SWE for BC screening. As for breast magnetic resonance imaging(MRI), even if it is useful in BC detection in women who have a strong family history of BC, it is not generally recommended as a screening tool. Moreover, based on the lack of randomized clinical trials showing a benefit of presurgical breast MRI in overall survival, it's integration into breast surgical operations remainsdebatable. Interestingly, in contrast to fine needle aspiration, core biopsy has gained popularity in presurgical diagnosis. Furthermore, after conservative surgery in patients with positive sentinel lymph nodes, the recent tendency is the shift from axillary dissection to axillary conserving strategies. While the accuracy of sentinel lymph node after neoadjuvant chemotherapy and second BC surgery remains controversial, more time is needed for evaluation and for determining the optimal interval between the two surgeries. Additionally, in the decision between immediate or delayed breast reconstruction, there is a tendency in the immediate use. In the prevention of BC, the controversial issue between tamoxifen and raloxifene becomes clear with raloxifene be more profitable through the toxicities of tamoxifen. However, the prevention of bone metastasis with bisphosphonates is still conflicting. Last but not least, in the follow-up of BC survivors, mammography, history and physical examination are the means of an early detection of BC recurrence.

Bioinformatics screening of breast cancer-related genes and potential drug research

Objective:To search the the differentially expressed genes between breast cell carcinoma tissues and normal tissues by using bioinformatics technology,and the potential therapeutic drugs for breast cancer were identified,which can provide reference for clinical immune targeted therapy and drug therapy of breast cancer in the future.Methods:"Breast cancer"was searched by using Gene Expression Omnibus(GEO),and GSE79586 chip data was downloaded.The differentially expressed genes in the control group and the breast cancer model group were screened by using bio-communication technology and subjected to GO function analysis,KEGG pathway analysis,differential gene characteristic expression analysis and protein-protein interaction network(PPI)analysis,and the analysis results were further visualized.Prognosis analysis,related function prediction and immune infiltration analysis were performed using the GEPIA,GeneMANIA,and Timer2.0 databases,respectively.Finally,the compounds with potential therapeutic effects on breast cancer are identified through Connectivity Map(CMap).Western blotting and real-time PCR(RT-PCR)were used to verify the core genes and potential therapeutic agents with the highest correlation in vitro.Results:A total of 3916 differentially expressed genes including 1786 up-regulated genes and 2130 down-regulated genes were screened.GO analysis showed that the differential genes were mainly involved in the positive regulation of phosphorylation,secretory vesicles,racemase and epimerase activities.KEGG analysis showed that differential genes were involved in systemic lupus erythematosus,alcoholism,sticky spots,amoebic dysentery Ras signal pathways and other disease pathways.The characteristic expression analysis of differential genes showed that MEK inhibitors,HSP90 inhibitors and signal transduction pathway kinase inhibitors were drugs similar to the differential genes.PPI results showed that H2AFJ,TFF1,GATA3,FOXA1,and CDH1 were core genes related to breast cancer.Two core genes of H2AFJ and TFF1 with the highest correlation were further selected for GEPIA analysis.The results of the analysis showed that the mRNA expression levels of H2AFJ and TFF1 in breast cancer cells were significantly higher than those in normal tissues,and there was a significant correlation with the pathological staging,overall survival rate and disease-free survival rate of breast cancer patients.H2AFJ and TFF1 may be potential prognostic biomarkers for survival of breast cancer patients.The functions of differentially expressed H2AFJ and TFF1 are mainly related to hormone receptor binding,epithelial structure maintenance and epigenetic negative regulation of genes,chromatin tissue involved in negative regulation of transcription,etc.The results of immune infiltration showed that the expressions of H2AFJ and TFF1 had a significant correlation with the infiltration of macrophages,neutrophils,monocytes,CD4+T,CD8+T,B lymphocytes and other immune cells.CMap results showed that compounds such as Gefitinib,Alpelisib,Sorafenib,and Sunitinib had potential therapeutic effects on breast cancer.Western blot and RT-PCR results showed that H2AFJ and TFF1 were significantly overexpressed in breast cancer cells.Gefitinib significantly inhibited the expression of H2AFJ and TFF1 in breast cancer cells(P<0.05,P<0.01).Conclusion:In this study,differentially expressed genes between breast cell carcinoma tissues and normal tissues were screened out by bioinformatics means to further identify key genes and compounds with potential therapeutic effects in the onset process of breast cancer and to further verify the effectiveness of the screened drugs on breast cancer through experiments.It will provide reference for clinical research and development of new drugs against breast cancer in the future in order to develop more effective treatment options.

Women’s Awareness of Mammographic Screening for Breast Cancer in Togo

Breast cancer represents a real public health problem due to its increasing frequency, its seriousness and its psycho-social implications. The aims of this study were to determine the level of awareness of women on the performance of mammography in the diagnosis and screening for breast cancer. This was a cross-sectional study over a period of 4 months (from October 1, 2016 to January 31, 2017) in Togo. It consisted in completing a questionnaire distributed to women above 30 years of age. The mean age of the women was 42 years. 88.8% of them had heard of breast cancer. There was a link between age, occupation, level of education and awareness of breast cancer. Only 20.8% of women had heard of mammography, with a link between awareness of mammography and age, occupation, and level of education. A link was noted between awareness of breast cancer and awareness of mammography. Information on mammographic breast cancer screening is inadequate in Togo.

Expectations of Patients with a Diagnosis of Breast Cancer When Meeting the Psycho-Oncologist: Beyond the Assistance of the Oncologist

Objective: Cancer patients consider the oncologist as their main resource insofar as the medical needs generally take precedence over psychological needs. Nevertheless, the psychological intervention is also important. The systematic consultation implemented in our hospital after a diagnosis of cancer is a manner to answer patients’ psychological needs. In a survey, we assessed the satisfaction and expectations of the patients about this consultation. Methods: One year after a diagnosis of breast cancer, 104 patients answered a retrospective questionnaire assessing: socio- demographic data, cancer medical information, systematic consultation satisfaction, patients’ expectations for a systematic intervention, and patients’ characteristics who began a psychological follow-up. Results: 72.1% of the patients were satisfied with having the opportunity to consult a psychologist during a systematic consultation after cancer diagnosis. Their expectations were to have opportunities of emotional expression, reassurance, obtaining additional medical information, talking about their fear over additional treatments, and identifying further support. 28.8% of the patients re-contacted the psychologist for further help after the systematic consultation. They were significantly younger (p < 0.001) than the others. Conclusions: Besides the importance of support by medical specialists [1], offering the opportunity to breast cancer patients to discuss inner feelings and treatment expectations during a systematic psychological consultation was useful for most of them. About one third of the patients asked for a further consultation with a psychologist after a first systematic consultation, especially younger patients. This stressed the importance of the role of psychologists for psycho-social support of the patient after cancer treatment.

移动信息化访视平台在乳腺癌改良根治术患者中的应用效果

目的探讨移动信息化访视平台在乳腺癌改良根治术患者中的应用效果。方法选取2023年2月至9月于东南大学附属中大医院手术室初次接受择期乳腺癌改良根治术的180例患者,采用随机数字表法将其分为两组,每组90例,对照组脱落6例,最终纳入对照组84例和观察组90例。对照组采用常规口头宣教和发放宣传册的方式进行访视,观察组采用移动信息化访视平台进行访视。比较两组术前访视时间、患者满意度、术前准备完善情况、访视前及麻醉等待期焦虑自评量表(SAS)和抑郁自评量表(SDS)评分。结果观察组术前访视时间短于对照组,患者满意度高于对照组,术前准备完善率高于对照组(P<0.05)。访视前,两组SAS和SDS评分比较,差异无统计学意义(P>0.05);麻醉等待期,两组SAS和SDS评分均低于访视前,且观察组低于对照组(P<0.05)。结论移动信息化访视平台可显著缩短乳腺癌改良根治术患者术前访视时间,提高访视效率和术前准备完善率,缓解患者术前抑郁、焦虑程度,提高患者满意度,使围手术期访视工作更规范、便捷和高效,为手术和患者安全提供保障。

信息-动机-行为技巧模型联合心理干预对乳腺癌术后患者情绪状态及生活质量的影响

目的探讨信息-动机-行为技巧模型(IMB)联合心理干预对乳腺癌术后患者情绪状态及生活质量的影响。方法依据干预方式的不同将92例乳腺癌手术患者分为对照组(n=50)和联合组(n=42),对照组患者给予常规干预,联合组患者给予IMB模式联合心理干预。比较两组患者的情绪状态[抑郁自评量表(SDS)、焦虑自评量表(SAS)]、功能锻炼依从性、生活质量[世界卫生组织生存质量测定量表简表(WHOQOL-BREF)]、并发症发生情况及干预满意度。结果干预后,两组患者SDS、SAS评分均低于本组干预前,WHOQOL-BREF各维度评分均高于本组干预前,联合组患者SDS、SAS评分均低于对照组,WHOQOL-BREF各维度评分均高于对照组,差异均有统计学意义(P﹤0.05)。干预后,两组患者术后注意事项依从、身体功能锻炼依从、主动寻求建议依从评分均高于本组干预前,联合组患者术后注意事项依从、身体功能锻炼依从、主动寻求建议依从评分均高于对照组,差异均有统计学意义(P﹤0.05)。联合组患者的术后并发症总发生率低于对照组,总满意度高于对照组,差异均有统计学意义(P﹤0.05)。结论IMB模式联合心理干预能明显改善乳腺癌术后患者的情绪状态,提高生活质量和功能锻炼依从性,降低术后并发症发生率,从而提高干预满意度。

乳腺癌患者健康信息需求研究的范围综述

目的对乳腺癌患者健康信息需求相关研究进行范围综述,为未来有关研究提供参考。方法计算机检索PubMed、Web of Science、CINAHL、Embase、Cochrane Library、中国知网、维普、万方数据库中有关乳腺癌患者健康信息需求的文献,检索时限从建库至2023年7月2日,并由2名研究者对文献进行筛选阅读、提取归纳、分析结果。结果本研究共纳入15篇文献。患者存在治疗相关、疾病基本知识、康复保健、社会心理方面健康信息需求,不同疾病阶段乳腺癌患者的信息需求有差异。结论未来应进一步完善乳腺癌健康信息需求评估工具,通过纵向追踪探讨患者不同疾病阶段信息需求的变化规律,构建乳腺癌患者信息需求干预方案并验证干预效果。

基于信息-动机-行为技巧模型的健康教育在乳腺癌放疗患者中的应用效果

目的探讨基于信息-动机-行为技巧模型(IMB)的健康教育在乳腺癌放疗患者中的应用效果。方法依据干预方式的不同将86例乳腺癌放疗患者分为对照组(n=44)和观察组(n=42),对照组患者接受常规干预,观察组患者接受基于IMB的健康教育。比较两组患者的自我管理效能[中文版癌症自我管理效能感量表(C-SUPPH)]、心理状况[正性负性情绪自评量表(PANAS)]、不良反应发生情况和满意度。结果干预后,两组患者C-SUPPH各维度评分均高于本组干预前,观察组患者C-SUPPH各维度评分均高于对照组,差异均有统计学意义(P﹤0.05)。干预后,两组患者正性情绪评分均高于本组干预前,负性情绪评分均低于本组干预前,观察组患者正性情绪评分高于对照组,负性情绪评分低于对照组,差异均有统计学意义(P﹤0.05)。观察组患者的不良反应总发生率为7.14%,低于对照组患者的22.73%,差异有统计学意义(P﹤0.05)。观察组患者的满意度为100%,明显高于对照组患者的79.55%,差异有统计学意义(P﹤0.01)。结论基于IMB的健康教育可有效改善乳腺癌放疗患者的自我管理效能,改善心理状态,降低不良反应发生率,提高干预满意度。

基于用户体验要素模型的乳腺癌相关淋巴水肿信息系统的研发与可用性评价

目的研发可供护理人员使用的乳腺癌相关淋巴水肿信息系统,并评价该系统的可用性。方法基于用户体验要素模型研发乳腺癌相关淋巴水肿信息系统,并邀请42名乳腺癌相关淋巴水肿护理团队成员采用系统可用性量表对该系统进行评价。结果乳腺癌相关淋巴水肿信息系统包括信息登记、信息查询、信息统计、临床研究四大模块。淋巴水肿护理团队成员对该系统可用性评价总分为(83.11±10.86)分。结论基于用户体验要素模型的乳腺癌相关淋巴水肿信息系统具有良好的可用性,为护理人员向淋巴水肿患者提供全周期与全方位的管理保驾护航。

WB-DWI对于乳腺癌患者术后临床评价

目的:研究核磁共振全身弥散加权成像(WB-DWI)在乳腺癌患者术后随访评价中的应用价值。方法:选取2020年5月-2023年6月在我院接受手术治疗的乳腺癌患者200例为对象,均在本院接受乳腺癌全切术治疗,术后定期随访中分别进行WB-DWI检查,并以术后病理随访结果为金标准,计算WB-DWI检查对乳腺癌术后复发、远处转移、腋窝淋巴结转移的诊断价值。结果:WB-DWI对乳腺癌术后复发或远处转移的诊断准确率、灵敏度和特异度分别为97.00%、97.44%、96.72%;WB-DWI对术后腋窝淋巴结转移的诊断准确率、灵敏度和特异度分别为94.00%、90.53%、97.14%;转移性淋巴结的ADC值明显低于非转移性淋巴结的ADC值(P<0.05),且ADC值对腋窝淋巴结转移的最佳诊断阈值为0.895×10^(-3)mm^(2)/s,AUC值为0.795;不同骨组织转移灶的ADC值明显低于正常骨组织的ADC值(P<0.05),且ADC值对骨转移的最佳诊断阈值为0.983×10^(-3)mm^(2)/s,AUC值为0.834。结论:乳腺癌术后的临床评价中应用WB-DWI检查具有快速、无创、无需造影剂、安全、无辐射、可短期重复扫描等优点,能得到类似PET-CT图像,敏感度高,能早期检出转移灶和复发灶,为乳腺癌术后复发和转移的早期发现提供可靠的信息,值得推广应用。

中文版患者报告结局测量信息系统特征集的研制

目的通过认知性访谈分析中文版患者报告结局测量信息系统特征集(patient-reported outcomes measurement information system,PROMIS-57 profile)在中国人群中的适用性,形成与原量表语义和概念具有等价性的中文版量表。方法采用目的抽样法,以2021年2—5月从上海市某三甲医院招募的10例乳腺癌患者及5例健康人群为研究对象,通过2轮认知性访谈分析受访者对翻译后的PROMIS-57 profile各条目的理解程度,根据访谈结果修订条目。结果第1轮访谈结果显示,大多数受访者可较快理解条目信息,但部分条目存在文化差异以及用词过于书面化等问题,经讨论后进行了对应修改。第2轮访谈结果显示,在结合受访者建议和专家咨询讨论后修订的条目与原量表语义一致。结论运用认知性访谈可解决量表汉化过程中的理解差异及文化适应问题,可提高量表的适用性,经修订后的中文版PROMIS-57 profile具有理想的接受度。

基于IKAP模式的护理干预在乳腺癌术后患侧上肢淋巴水肿患者中的应用效果

目的观察基于信息-知识-信念-行为(IKAP)模式护理干预在乳腺癌术后患侧上肢淋巴水肿患者中的应用效果。方法将郑州大学第一附属医院2022年1月至2023年12月收治的74例乳腺癌术后患侧上肢淋巴水肿患者纳入本研究,按照随机数字表法,分为观察组与对照组。对照组(37例)接受常规护理,观察组(37例)在此基础上接受基于IKAP模式的护理干预。护理前后评价患者的疼痛程度、自我照护依从性、生活质量、自我管理能力,并比较两组护理满意度。结果护理后,观察组自我照护依从性提高、视觉模拟量表(VAS)评分下降,较之对照组更优(P<0.05);观察组正性态度、缓解压力、自我决策评分增高,较之对照组更高(P<0.05);观察组共性模板、乳腺癌特异模板、生活质量评分下降,较之对照组更低(P<0.05);观察组患者的护理总满意度为94.59%,与对照组的83.78%比较,观察组更高(P<0.05)。结论基于IKAP模式的护理干预可提高乳腺癌术后患侧上肢淋巴水肿患者的自我照护依从性,降低术后疼痛程度,提高患者自我管理能力与护理满意度,且生活质量更高。

分化型甲状腺癌人工智能语音随访系统的构建及应用

目的构建分化型甲状腺癌人工智能语音随访系统,评价该系统信息采集的完整性和准确性。方法根据分化型甲状腺癌患者术后用药及复查情况,构建分化型甲状腺癌人工智能语音随访系统。对2024年2月25-29日本院甲乳血管外科甲状腺癌数据库管理系统中未进行随访的2471例分化型甲状腺癌患者进行电话随访,并随机抽取10%,对220例患者的通话记录进行完整性和准确性分析。结果本研究成功构建分化型甲状腺癌人工智能语音随访系统,总体电话接通率为88.9%。对于呼叫成功的患者,人工智能语音随访系统的随访平均用时(1.7±0.5)min,总体信息采集完整率为83.8%,术后3个月随访信息采集完整率为92.9%,术后长期随访信息采集完整率为82.7%,差异有统计学意义(χ^(2)=15.200,P<0.001)。该随访系统信息采集准确率为94.1%。说方言随访者和说普通话随访者的信息采集准确率分别为92.2%和95.4%,差异无统计学意义(χ^(2)=0.957,P=0.389)。结论分化型甲状腺癌人工智能语音随访系统具有较高的信息采集效率、完整性和准确性,可降低随访人力成本,在大规模分化型甲状腺癌人群随访中具有良好的应用前景。

人工智能语音随访系统在乳腺癌日间手术患者随访中的应用分析

目的构建乳腺癌日间手术患者人工智能语音随访系统,评价临床应用效果。方法根据乳腺癌日间手术患者不同阶段的随访要求,设计人工智能语音随访系统。对电话接通率、随访耗时、信息采集完整率、字段提取准确率以及满意度等进行比较分析。结果人工智能语音随访系统共随访432例乳腺癌日间手术患者,共执行1089条随访记录,电话接通率为90.9%,信息采集完整率为97.7%,字段提取准确率为94.9%;第一次回访平均耗时(2.1±0.42)min,第二次回访平均耗时(1.6±0.45)min,第三次回访平均耗时(1.9±0.33)min,生存随访平均耗时(2.1±0.32)min,大大缩短了随访时间。结论人工智能语音随访系统可为乳腺癌日间手术患者搭建持续、快捷的医患沟通路径,提高了随访率,节约了人力成本,提高了服务质量。

智能交互式护理信息支持系统对乳腺癌患者睡眠质量的影响

目的:探究构建智能交互式护理信息支持系统对乳腺癌患者护理期间生命质量、睡眠质量的影响。方法:选取2022年8月至2023年8月福建医科大学附属第一医院甲状腺乳腺外科经临床综合检查确诊为乳腺癌患者72例作为研究对象,按照随机数字表法分为对照组和观察组,每组36例。对照组实施常规护理,观察组以常规护理为基础构建智能交互式护理信息支持系统,比较2组患者睡眠质量、生命质量、自我管理效能。结果:观察组患者理查兹-坎贝尔睡眠量表(RCSQ)各项指标高于对照组(P<0.05);观察组患者生命质量量表(QOLLTI-F)各项指标高于对照组(P<0.05);与对照组比较,观察组自我管理效能症状管理以及疾病共性管理评分及总分均高于对照组(P<0.05)。结论:乳腺癌患者在护理期间构建智能交互式护理信息支持系统能够提高患者生命质量、睡眠质量、自我管理效能。